Study: HDL cholesterol, heart risk aren't linked in statin users

07/22/2010 | HealthDay News

A U.S. study suggests that patients with a low level of LDL, or "bad," cholesterol as a result of using a high-dose statin, such as AstraZeneca's Crestor, might not benefit from a high level of HDL, or "good," cholesterol. The finding suggests that "once on a high-dose statin, it is unclear if HDL cholesterol remains an important determinant of residual risk" of cardiovascular disease, the lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN